this clinical trial is designed to study the cardiovascular and renal outcomes of hypertensives after an integrated management of blood pressure and other cardiometabolic risks. it is a multicenter prospective cohort study.
Study Type
OBSERVATIONAL
Enrollment
30,000
establish an integrated management on cardio-metabolic risk factors including hypertension by updating and upgrading the daily practice of practitioners and screening patients
HuashanH
Shanghai, Shanghai Municipality, China
complex outcome
number of participants with 3P-MACE events(cardiovascular deaths, non-fatal myocardial infarction, non-fatal stroke)
Time frame: follow-up 1 year
coronary angioplasty
number of participants with coronary angioplasty
Time frame: follow-up 1 year
acute renal failure
number of participants with acute renal failure(eGFR decreases by 50% or \<15ml/min/1.73m2, dialysis or renal death)
Time frame: follow-up 1 year
acute heart failure
number of participants with acute heart failure(non-scheduled hospitalizations due to heart failure or required intravenous medication)
Time frame: follow-up 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.